Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol... see more

NDAQ:TLRY - Post Discussion

Tilray Brands Inc > Tilray Brands - Germany
View:
Post by Ventura2020 on Dec 05, 2023 2:00pm

Tilray Brands - Germany

Nice tease on the SP with Germany coming into play for a select few LP's that have large stake in the German market.
Unfortunately the momentum was disrupted due to the delay on the vote into the New Year. 

It looks like with the comment below, the 100kg per annum will be lifted, along with strains.

Now it’s Germany’s turn to welcome a level playing field

The tender procedure for the cultivation of the medicine, which limits domestic production to just three companies, is set to be abolished, while the amount that can be grown will no longer be capped.

Dr Constantin von der Groeben

Dr Constantin von der Groeben is the co-founder and managing director of Demecan, one of the three companies licensed to cultivate in Germany. 

He told the Business of Cannabisthe move would give local firms a significant leg up.

We are now free to cultivate as much cannabis as we want and can choose the strains we want to grow,” he said.

“Finally there will be a level playing field and German cultivators can compete properly with importers. Given our lower production costs and easy logistics, we will hopefully see a boom in medical cultivation in Germany.”

He added the three current licence holders – Demecan, Aurora and Tilray – will “probably” benefit the most given their first-mover advantage.

https://www.cannabiz.com.au/now-its-germanys-turn-to-welcome-a-level-playing-field/

Comment by Ventura2020 on Dec 05, 2023 2:04pm
Correction - 1000 kg limit per annum 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities